Hemoconcentrators: Medica in the US market
Medica S.p.A. 510k authorization from the US FDA for the distribution of hemoconcentrators on the US market.
Medica S.p.A. has received the 510K distribution authorization from the US Food and Drug Administration (FDA), through its subsidiary Tecnoideal America, of hemoconcentrators, produced by Medica, on the US market.
These devices are intended for use on adult patients for the removal of excess fluids from the blood for the purpose of restoring physiological blood conditions during or at the end of cardiopulmonary bypass surgery.